Pharmaceutical microbiology is of crucial importance to the development and manufacture of pharmaceutical drugs, biologics and devices. Set to take place on the 21st and 22nd January 2015, the event will provide essential insights in to the latest advancements in practice and technology, developments in regulation and harmonisation of international practice and evolving methods and the latest technology.

Join us as we explore key issues in data review and analysis, contamination control strategies, strategies for low endotoxin recovery and best practice in sterile and non-sterile manufacture. Hear presentations from the heart of industry, addressing real world case studies on the benefits and challenges of rapid methods, risk assessments and objectionable organisms. Share the wisdom of respected consultants and get the regulators perspective on recent changes and issues under review.

Benefits of attending:

• Discover the latest in the development and management of sterilisation and validation
  processes
• Benefit from shared learning and case studies to enhance your practice
• Understand data review and analysis for pharmaceutical microbiology
• Tune in to developments in bioburden and biofilm control strategies
• Look in depth at issues of objectionable organism management
• Hear specialist advice on contamination control and risk assessment

Who should attend:

Chief Executives, Vice Presidents, Heads, Directors, Chief Scientists, Principle Scientists, and Project Leaders, Managers, in:

• Microbiologists
• Biological manufacture and production
• Quality control
• Quality assurance
• Antimicrobial and biocide research
• Biotech research and development
• Sterile lab management
• Sterile facilities design and construction
• Compliance
• Regulatory Affairs
• Validation

Follow this link to view more and book